Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2015 · 10-Q
Revenue$0.00$0.00— vs Q2 2014 Net Income-$2.01M-$2.01MN/M vs Q2 2014 EPS Diluted-$0.02-$0.02N/M vs Q2 2014 Operating Income-$1,041,785N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2015 · filed Aug 13, 2015 · 44 d after period end